CleanSpace Holdings Limited (CSX.AX)
AUD 0.42
(13.51%)
AUD 0.42
(13.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 698.59 Thousand AUD | -21.09% |
| 2023 | 885.33 Thousand AUD | 121.63% |
| 2022 | -4.09 Million AUD | 77.03% |
| 2021 | -17.82 Million AUD | 37.68% |
| 2020 | -28.6 Million AUD | -5493.07% |
| 2019 | 530.31 Thousand AUD | 127.75% |
| 2018 | -1.91 Million AUD | -270.58% |
| 2017 | 1.12 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.84 Million AUD | 145.08% |
| 2024 Q4 | 698.59 Thousand AUD | 3614.93% |
| 2024 FY | 698.59 Thousand AUD | -21.09% |
| 2024 Q3 | 18.8 Thousand AUD | -99.2% |
| 2024 Q2 | 2.35 Million AUD | 27.54% |
| 2023 Q4 | -4.09 Million AUD | -1117.69% |
| 2023 Q2 | 1.1 Million AUD | 70.68% |
| 2023 FY | 885.33 Thousand AUD | 121.63% |
| 2023 Q1 | 649.59 Thousand AUD | 115.87% |
| 2023 Q3 | 402.28 Thousand AUD | -63.72% |
| 2022 Q4 | -4.09 Million AUD | 9.68% |
| 2022 Q3 | -4.53 Million AUD | 55.76% |
| 2022 Q2 | -10.24 Million AUD | 3.96% |
| 2022 Q1 | -10.66 Million AUD | 40.15% |
| 2022 FY | -4.09 Million AUD | 77.03% |
| 2021 Q1 | -38.26 Million AUD | -1925.98% |
| 2021 FY | -17.82 Million AUD | 37.68% |
| 2021 Q2 | -37.83 Million AUD | 1.13% |
| 2021 Q4 | -17.82 Million AUD | 2.24% |
| 2021 Q3 | -18.23 Million AUD | 51.81% |
| 2020 Q1 | 3.84 Million AUD | 0.0% |
| 2020 Q3 | -2.02 Million AUD | 0.0% |
| 2020 Q4 | -1.88 Million AUD | 6.51% |
| 2020 FY | -28.6 Million AUD | -5493.07% |
| 2019 FY | 530.31 Thousand AUD | 127.75% |
| 2018 FY | -1.91 Million AUD | -270.58% |
| 2017 FY | 1.12 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 102.741% |
| Adherium Limited | -6.1 Million AUD | 111.444% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 118.643% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 119.387% |
| Anteris Technologies Ltd | -28.49 Million AUD | 102.451% |
| Control Bionics Limited | -19.02 Thousand AUD | 3772.548% |
| CardieX Limited | 2.74 Million AUD | 74.563% |
| Compumedics Limited | 5.08 Million AUD | 86.267% |
| Cochlear Limited | -269.9 Million AUD | 100.259% |
| Cyclopharm Limited | -7.49 Million AUD | 109.316% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 104.449% |
| Nova Eye Medical Limited | -2.8 Million AUD | 124.932% |
| HeraMED Limited | -799.34 Thousand AUD | 187.395% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 95.176% |
| ImpediMed Limited | -23.48 Million AUD | 102.974% |
| InhaleRx Limited | -155.54 Thousand AUD | 549.128% |
| LBT Innovations Limited | -604 Thousand AUD | 215.661% |
| Micro-X Limited | 826.99 Thousand AUD | 15.527% |
| Neurotech International Limited | -2.11 Million AUD | 133.101% |
| OncoSil Medical Limited | -4.43 Million AUD | 115.767% |
| PolyNovo Limited | -30.52 Million AUD | 102.288% |
| Respiri Limited | 413.68 Thousand AUD | -68.869% |
| SomnoMed Limited | -15.16 Million AUD | 104.607% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 113.171% |
| Uscom Limited | -1.53 Million AUD | 145.641% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 117.11% |